PortfoliosLab logo
PortfoliosLab logo
Tools
Portfolios
Screeners
Discussions
ACOR vs. FLCNX
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility

Correlation

The correlation between ACOR and FLCNX is 0.22, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.

ACOR vs. FLCNX

Last updated May 31, 2025

Compare and contrast key facts about Acorda Therapeutics, Inc. (ACOR) and Fidelity Contrafund K6 (FLCNX).

FLCNX is managed by Fidelity. It was launched on May 25, 2017.

Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: ACOR or FLCNX.

Performance

ACOR vs. FLCNX - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Acorda Therapeutics, Inc. (ACOR) and Fidelity Contrafund K6 (FLCNX). The values are adjusted to include any dividend payments, if applicable.

Loading data...

Key characteristics

Returns By Period

ACOR

YTD

N/A

1M

N/A

6M

N/A

1Y

N/A

3Y*

N/A

5Y*

N/A

10Y*

N/A

FLCNX

YTD

5.11%

1M

8.80%

6M

3.78%

1Y

18.62%

3Y*

21.83%

5Y*

17.27%

10Y*

N/A

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.

Acorda Therapeutics, Inc.

Fidelity Contrafund K6

Go deeper with the Portfolio Analysis tool — backtest performance, assess risk, compare to benchmarks, and more

Risk-Adjusted Performance

ACOR vs. FLCNX — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.
ACOR
The Risk-Adjusted Performance Rank of ACOR is 66
Overall Rank
The Sharpe Ratio Rank of ACOR is 1414
Sharpe Ratio Rank
The Sortino Ratio Rank of ACOR is 99
Sortino Ratio Rank
The Omega Ratio Rank of ACOR is 66
Omega Ratio Rank
The Calmar Ratio Rank of ACOR is 22
Calmar Ratio Rank
The Martin Ratio Rank of ACOR is 00
Martin Ratio Rank
FLCNX
The Risk-Adjusted Performance Rank of FLCNX is 6565
Overall Rank
The Sharpe Ratio Rank of FLCNX is 6161
Sharpe Ratio Rank
The Sortino Ratio Rank of FLCNX is 6464
Sortino Ratio Rank
The Omega Ratio Rank of FLCNX is 6666
Omega Ratio Rank
The Calmar Ratio Rank of FLCNX is 7272
Calmar Ratio Rank
The Martin Ratio Rank of FLCNX is 6363
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

ACOR vs. FLCNX - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Acorda Therapeutics, Inc. (ACOR) and Fidelity Contrafund K6 (FLCNX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

No data
No data
No data
No data

Loading data...

Go to the full Sharpe Ratio tool to analyze any stock or portfolio. Customize time frames, set your own risk-free rate, and more

Dividends

ACOR vs. FLCNX - Dividend Comparison

ACOR has not paid dividends to shareholders, while FLCNX's dividend yield for the trailing twelve months is around 0.41%.

TTM20242023202220212020201920182017
ACOR
Acorda Therapeutics, Inc.		0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
FLCNX
Fidelity Contrafund K6		0.41%0.36%0.49%1.18%0.46%0.21%0.30%0.33%0.15%

Drawdowns

ACOR vs. FLCNX - Drawdown Comparison

Loading data...

Go to the full Drawdowns tool for more analysis options, including inflation-adjusted drawdowns, and more

Volatility

ACOR vs. FLCNX - Volatility Comparison

Loading data...